Linden Capital To Acquire SeraCare For $4/Share

Symbols: SRLS
Posted in: News, M&A
Share

SeraCare Life Sciences Inc (NASDAQ: SRLS) agreed to be bought by Linden Capital Partners for $4 per share.

SeraCare's board had approved the terms of the deal. The offer price represents a 19% premium to the closing price of $3.37 on Friday.

SRLS shares gained 6.23% to close at $3.58 on Friday.


 
 
< Previous
China has Debt Too
Next >
A Peek Into The Market Before The Trading Starts
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust